Cadence Neuroscience raises $15M for epilepsy treatment created at Mayo Clinic

This post was originally published on this site
Cadence chief scientific officer Doug Sheffield (left) and CEO Kent Leyde. (Cadence Photo)

Medical device startup Cadence Neuroscience raised $15 million to develop a therapy for the treatment of epilepsy. The Series A round was led by Jazz Venture Partners, and the company also received support from Mayo Clinic


Check out